Transforming science into health
ImunoTera offers an unprecedented biotech platform capable of restoring and activating immune system functions.
The platform, called Act-Tera, is based on a recombinant protein designed with high therapeutic precision to fight different types of cancer.
Our first product, the TERAH-7 protein, targets precancerous lesions and cancer related to the human papilloma virus, HPV. How it works:
MECHANISMS OF ACTION
With 100% Brazilian technology, the therapeutic vaccine increases the body's natural defenses against cancer, through three mechanisms:
ImunoTera's therapeutic vaccine showed synergism with other treatments, such as chemotherapy, with high efficacy in fighting HPV-induced cancer in the pre-clinical phase.